SEM
Income statement / Annual
Last year (2025), Select Medical Holdings Corporation's total revenue was $5.45 B,
an increase of 5.12% from the previous year.
In 2025, Select Medical Holdings Corporation's net income was $146.22 M.
See Select Medical Holdings Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$5.45 B |
$5.19 B |
$6.66 B |
$6.33 B |
$6.20 B |
$5.53 B |
$5.45 B |
$5.08 B |
$4.44 B |
$4.29 B |
| Cost of Revenue |
$4.82 B
|
$4.55 B
|
$5.73 B
|
$5.60 B
|
$5.29 B
|
$4.71 B
|
$4.64 B
|
$4.34 B
|
$3.73 B
|
$3.66 B
|
| Gross Profit |
$629.30 M
|
$633.64 M
|
$932.04 M
|
$733.38 M
|
$919.37 M
|
$821.34 M
|
$812.92 M
|
$740.20 M
|
$709.43 M
|
$621.18 M
|
| Gross Profit Ratio |
0.12
|
0.12
|
0.14
|
0.12
|
0.15
|
0.15
|
0.15
|
0.15
|
0.16
|
0.14
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$154.41 M
|
$225.87 M
|
$170.19 M
|
$153.04 M
|
$146.98 M
|
$138.04 M
|
$128.46 M
|
$121.27 M
|
$114.05 M
|
$106.93 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$154.41 M
|
$225.87 M
|
$170.19 M
|
$153.04 M
|
$146.98 M
|
$138.04 M
|
$128.46 M
|
$121.27 M
|
$114.05 M
|
$106.93 M
|
| Other Expenses |
$140.30 M
|
$139.46 M
|
$206.97 M
|
$177.06 M
|
$58.62 M
|
$115.65 M
|
$212.58 M
|
$201.66 M
|
-$49.00 K
|
$42.65 M
|
| Operating Expenses |
$294.72 M
|
$365.33 M
|
$377.17 M
|
$330.09 M
|
$205.59 M
|
$253.68 M
|
$341.04 M
|
$322.92 M
|
$274.06 M
|
$252.24 M
|
| Cost And Expenses |
$5.12 B
|
$4.92 B
|
$6.11 B
|
$5.93 B
|
$5.49 B
|
$4.96 B
|
$4.98 B
|
$4.66 B
|
$4.01 B
|
$3.92 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$5.35 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$117.58 M
|
$128.61 M
|
$198.64 M
|
$169.11 M
|
$135.99 M
|
$153.01 M
|
$200.57 M
|
$198.49 M
|
$154.70 M
|
$170.08 M
|
| Depreciation & Amortization |
$140.30 M
|
$203.89 M
|
$208.74 M
|
$205.83 M
|
$202.65 M
|
$205.66 M
|
$212.58 M
|
$201.66 M
|
$160.01 M
|
$145.31 M
|
| EBITDA |
$530.64 M |
$507.27 M |
$789.74 M |
$635.52 M |
$968.35 M |
$683.30 M |
$677.90 M |
$621.83 M |
$517.18 M |
$448.39 M |
| EBITDA Ratio |
0.1
|
0.1
|
0.12
|
0.1
|
0.16
|
0.12
|
0.12
|
0.12
|
0.12
|
0.1
|
| Operating Income Ratio |
0.06
|
0.05
|
0.08
|
0.06
|
0.12
|
0.1
|
0.09
|
0.08
|
0.08
|
0.07
|
| Total Other Income/Expenses Net |
-$61.83 M
|
-$93.55 M
|
-$172.52 M
|
-$142.70 M
|
-$84.05 M
|
-$111.18 M
|
-$207.13 M
|
-$181.73 M
|
-$153.42 M
|
-$119.11 M
|
| Income Before Tax |
$272.75 M
|
$174.77 M
|
$382.36 M
|
$260.58 M
|
$629.72 M
|
$456.47 M
|
$264.75 M
|
$235.55 M
|
$202.46 M
|
$180.73 M
|
| Income Before Tax Ratio |
0.05
|
0.03
|
0.06
|
0.04
|
0.1
|
0.08
|
0.05
|
0.05
|
0.05
|
0.04
|
| Income Tax Expense |
$58.22 M
|
$44.78 M
|
$82.63 M
|
$62.55 M
|
$129.77 M
|
$111.87 M
|
$63.72 M
|
$58.61 M
|
-$18.18 M
|
$55.46 M
|
| Net Income |
$146.22 M
|
$214.04 M
|
$243.49 M
|
$158.99 M
|
$402.23 M
|
$259.00 M
|
$148.45 M
|
$137.84 M
|
$177.18 M
|
$115.41 M
|
| Net Income Ratio |
0.03
|
0.04
|
0.04
|
0.03
|
0.06
|
0.05
|
0.03
|
0.03
|
0.04
|
0.03
|
| EPS |
1.18 |
1.66 |
1.91 |
1.23 |
2.99 |
1.93 |
1.54 |
1.06 |
1.33 |
0.88 |
| EPS Diluted |
1.18 |
1.66 |
1.91 |
1.23 |
2.99 |
1.93 |
1.54 |
1.06 |
0.87 |
0.87 |
| Weighted Average Shares Out |
$123.51 M
|
$129.19 M
|
$123.11 M
|
$124.63 M
|
$130.25 M
|
$129.78 M
|
$130.25 M
|
$130.17 M
|
$128.96 M
|
$127.81 M
|
| Weighted Average Shares Out Diluted |
$123.51 M
|
$124.61 M
|
$123.11 M
|
$124.63 M
|
$130.25 M
|
$129.78 M
|
$130.28 M
|
$130.26 M
|
$129.13 M
|
$127.97 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
